BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8028219)

  • 1. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo].
    Sun B
    Kaku Igaku; 1994 May; 31(5):473-87. PubMed ID: 8028219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability].
    Sun B
    Kaku Igaku; 1994 May; 31(5):459-71. PubMed ID: 8028218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.
    Esteban JM; Schlom J; Gansow OA; Atcher RW; Brechbiel MW; Simpson DE; Colcher D
    J Nucl Med; 1987 May; 28(5):861-70. PubMed ID: 3106595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.
    Roselli M; Schlom J; Gansow OA; Raubitschek A; Mirzadeh S; Brechbiel MW; Colcher D
    J Nucl Med; 1989 May; 30(5):672-82. PubMed ID: 2785585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood.
    Kinuya S; Jeong JM; Garmestani K; Saga T; Camera L; Brechbiel MW; Gansow OA; Carrasquillo JA; Neumann RD; Paik CH
    J Nucl Med; 1994 Nov; 35(11):1851-7. PubMed ID: 7965168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled metabolites of proteins play a critical role in radioactivity elimination from the liver.
    Arano Y; Mukai T; Akizawa H; Uezono T; Motonari H; Wakisaka K; Kairiyama C; Yokoyama A
    Nucl Med Biol; 1995 Jul; 22(5):555-64. PubMed ID: 7581163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies.
    Roselli M; Schlom J; Gansow OA; Brechbiel MW; Mirzadeh S; Pippin CG; Milenic DE; Colcher D
    Int J Rad Appl Instrum B; 1991; 18(4):389-94. PubMed ID: 1864727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA).
    Camera L; Kinuya S; Garmestani K; Brechbiel MW; Wu C; Pai LH; McMurry TJ; Gansow OA; Pastan I; Paik CH
    Eur J Nucl Med; 1994 Jul; 21(7):640-6. PubMed ID: 7957350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.
    Deshpande SV; Subramanian R; McCall MJ; DeNardo SJ; DeNardo GL; Meares CF
    J Nucl Med; 1990 Feb; 31(2):218-24. PubMed ID: 2107283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice.
    Sharkey RM; Motta-Hennessy C; Gansow OA; Brechbiel MW; Fand I; Griffiths GL; Jones AL; Goldenberg DM
    Int J Cancer; 1990 Jul; 46(1):79-85. PubMed ID: 2114375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
    Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
    J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bifunctional HBED-derivative for labeling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DPTA and 131I-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors.
    Schuhmacher J; Klivényi G; Hull WE; Matys R; Hauser H; Kalthoff H; Schmiegel WH; Maier-Borst W; Matzku S
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):809-24. PubMed ID: 1428911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of indium-111- and yttrium-90-labeled linker-immunoconjugates in nude mice and dogs.
    Quadri SM; Vriesendorp HM; Leichner PK; Williams JR
    J Nucl Med; 1993 Jun; 34(6):938-45. PubMed ID: 8509861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
    Camera L; Kinuya S; Garmestani K; Wu C; Brechbiel MW; Pai LH; McMurry TJ; Gansow OA; Pastan I; Paik CH
    J Nucl Med; 1994 May; 35(5):882-9. PubMed ID: 8176477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
    Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
    J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationships in indium-111 radioimmunoconjugates.
    Brandt KD; Johnson DK
    Bioconjug Chem; 1992; 3(2):118-25. PubMed ID: 1515465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
    J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.